LRMR Larimar Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 4, 2026
$2,96
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$2,7252-Wochen-Tief
$6,4252-Wochen-Hoch
Marktkapitalisierung (MRQ)
$307M
P/E
-1.7
EPS
$-1.32
Ihre Abzeichen
52W-Spanne
$3–$6
Analystenbewertung
STRONG BUY
Kursziel
$14
P/E
-1.7
ROE
-167.4%
Nettogewinnmarge
·
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
LRMR Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$2.96
Marktkapitalisierung (MRQ)
$307M
P/E
-1.7
EPS
$-1.32
ROE
-167.4%
52W-Spanne
$3–$6
LRMR Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
Über Larimar Therapeutics, Inc. - Common Stock Unternehmensübersicht von Wikipedia
SektorHealthcare
BrancheBiotechnology
Mitarbeiter71
LandUS
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz·2016-12-31 → 2019-12-31
EPS$-1.322020-12-31 → 2024-12-31
Freier Cashflow$-113M2016-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | LRMR | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E | -1.75-Jahres-Durchschnitt ≈-3.4 | ≈-3.4 | · | · | |
| K/B (MRQ) | 2.45-Jahres-Durchschnitt ≈2.5 | ≈2.5 | 1.9 | Überbewertet | |
| Price / FCF (Kurs / FCF) | -2.25-Jahres-Durchschnitt ≈-4.6 | ≈-4.6 | · | · | |
| Price / Cash Flow (Kurs / Cashflow) | -2.25-Jahres-Durchschnitt ≈-4.7 | ≈-4.7 | · | · | |
| Price / Tangible Book (Kurs / Materieller Buchwert) | 3.15-Jahres-Durchschnitt ≈2.5 | ≈2.5 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | LRMR | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| ROA | -95.8%5-Jahres-Durchschnitt ≈-54.6% | ≈-54.6% | -47.5% | Schwach | |
| ROE | -167.4%5-Jahres-Durchschnitt ≈-71.7% | ≈-71.7% | -90.1% | Schwach | |
| ROIC | -220.9%5-Jahres-Durchschnitt ≈-87.2% | ≈-87.2% | -56.5% | Schwach |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | LRMR | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Liquiditätsgrad (MRQ) | 4.75-Jahres-Durchschnitt ≈7.8 | ≈7.8 | 5.2 | Im Einklang | |
| Quick Ratio | 1.35-Jahres-Durchschnitt ≈3.2 | ≈3.2 | 5.0 | Geringe Liquidität |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Für diese Kennzahlengruppe sind noch keine Daten verfügbar
Noch nicht genügend Fundamentaldaten vorhanden, um diese Kennzahlengruppe zu berechnen.
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Für diese Kennzahlengruppe sind noch keine Daten verfügbar
Noch nicht genügend Fundamentaldaten vorhanden, um diese Kennzahlengruppe zu berechnen.
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
-7.7%
Nächster Bericht
Nov 03, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 12, 2026 | $-0.30 | $-0.39 | 22.8% |
| 31. März 2026 | Mai 14, 2026 | $-0.31 | $-0.55 | 43.2% |
| 31. Dezember 2025 | $-0.73 | $-0.52 | -41.2% | |
| 30. September 2025 | $-0.61 | $-0.41 | -48.0% | |
| 30. Juni 2025 | $-0.41 | $-0.49 | 16.3% | |
| 31. März 2025 | $-0.46 | $-0.43 | -7.8% | |
| 31. Dezember 2024 | $-0.45 | $-0.32 | -39.1% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $0 | $0 | |
| R&D Expense | $154M | $73M | $28M | $24M | $38M | $31M | $21M | $48M | $41M | $40M | $55M | $27M | |
| SG&A Expense | $18M | $18M | $14M | $12M | $12M | $11M | $2M | $13M | $12M | $18M | $19M | $8M | |
| Operating Expenses | $172M | $91M | $42M | $37M | $50M | $43M | $23M | $61M | $53M | $58M | $74M | $36M | |
| Operating Income | $-172M | $-91M | $-42M | $-37M | $-50M | $-43M | $-23M | $-61M | $-53M | $-58M | $-74M | $-36M | |
| Interest Expense | · | · | · | · | · | · | $2M | $2M | $165.0K | $529.0K | $806.0K | $870.0K | |
| Interest Income | · | · | · | · | · | · | $2M | $2M | $996.0K | · | · | · | |
| Other Non-op | $7M | $10M | $5M | $1M | $-171.0K | $322.0K | $82.0K | $-246.0K | $971.0K | $347.0K | $-473.0K | $-946.0K | |
| Pretax Income | $-166M | $-81M | $-37M | $-35M | $-51M | $-42M | $-23M | $-61M | $-52M | $-58M | $-74M | $-36M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-166M | $-81M | $-37M | $-35M | $-51M | $-42M | $-23M | $-61M | $-52M | $-58M | $-74M | $-36M | |
| EPS (Basic) | · | $-1.32 | $-0.84 | $-1.37 | $-2.95 | $-3.57 | · | · | · | · | · | · | |
| EPS (Diluted) | · | $-1.32 | $-0.84 | $-1.37 | $-2.95 | $-3.57 | · | · | · | · | · | · | |
| Shares (Basic) | · | 61,256,084 | 43,901,241 | 25,761,394 | 17,164,284 | 11,883,155 | · | · | · | · | · | · | |
| Shares (Diluted) | · | 61,256,084 | 43,901,241 | 25,761,394 | 17,164,284 | 11,883,155 | · | · | · | · | · | · | |
| EBITDA | $-172M | $-91M | $-42M | $-37M | $-50M | $-43M | $-46M | $-61M | $-53M | $-58M | · | $-36M |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $85M | $33M | $27M | $27M | $70M | $68M | $1M | $49M | $41M | $32M | $36M | $58M | |
| Prepaid Expense | $5M | $12M | $3M | $2M | $2M | $5M | $4M | $2M | $2M | $1M | $2M | $1M | |
| Current Assets | $142M | $195M | $90M | $121M | $72M | $98M | $5M | $121M | $105M | $131M | $188M | $117M | |
| PP&E (Net) | $622.0K | $881.0K | $684.0K | $831.0K | $1M | $1M | $274.0K | $375.0K | $528.0K | $661.0K | $902.0K | $79.0K | |
| PP&E (Gross) | $3M | $2M | $2M | $2M | $2M | $1M | $453.0K | $925.0K | $1M | $981.0K | $1M | $129.0K | |
| Accum. Depreciation | $2M | $2M | $1M | $914.0K | $596.0K | $335.0K | $179.0K | $550.0K | $508.0K | $320.0K | $120.0K | $50.0K | |
| Other Non-current Assets | $523.0K | $596.0K | $659.0K | $638.0K | $669.0K | $419.0K | $90.0K | $57.0K | $57.0K | $61.0K | $94.0K | $242.0K | |
| Total Assets | $146M | $200M | $96M | $126M | $79M | $105M | $5M | $122M | $106M | $132M | $189M | $118M | |
| Accounts Payable | $5M | $2M | $1M | $2M | $2M | $3M | $4M | $4M | $3M | $3M | $7M | $2M | |
| Accrued Liabilities | $58M | $21M | $7M | $8M | $7M | $6M | $2M | $4M | $4M | $4M | $6M | $3M | |
| Short-term Debt | · | · | · | · | · | · | $7M | $5M | · | $4M | $3M | $1M | |
| Current Liabilities | $65M | $24M | $10M | $11M | $9M | $9M | $6M | $13M | $7M | $10M | $17M | $7M | |
| Capital Leases | $3M | $4M | $5M | $5M | $5M | $6M | $6M | · | · | · | · | · | |
| Total Liabilities | $68M | $28M | $14M | $16M | $14M | $15M | $6M | $28M | $27M | $10M | $20M | $13M | |
| Long-term Debt | · | · | · | · | · | · | $15M | $20M | $20M | $3M | · | · | |
| Total Debt | · | · | · | · | · | · | $7M | $5M | · | $4M | · | $1M | |
| Common Stock | $83.0K | $64.0K | $43.0K | $43.0K | $18.0K | $15.0K | $6.0K | $37.0K | $27.0K | $27.0K | $27.0K | $23.0K | |
| Paid-in Capital | $513M | · | · | · | · | · | · | · | · | · | · | · | |
| Retained Earnings | $-435M | $-269M | $-189M | $-152M | $-116M | $-66M | $-23M | $-351M | $-290M | $-238M | $-180M | $-105M | |
| AOCI | $54.0K | $148.0K | $81.0K | $-31.0K | · | $1.0K | $35.0K | $-33.0K | $-58.0K | $-80.0K | $-207.0K | $-35.0K | |
| Stockholders' Equity | $78M | $172M | $82M | $111M | $64M | $90M | $-694.0K | $3M | $78M | $122M | $169M | $104M | |
| Liabilities + Equity | $146M | $200M | $96M | $126M | $79M | $105M | $5M | $122M | $106M | $132M | $189M | $118M | |
| Shares Outstanding | 83,090,392 | 63,815,065 | 43,909,069 | 43,269,200 | 17,710,450 | 15,367,730 | 6,091,250 | 37,287,221 | 27,489,457 | 27,332,551 | 27,242,503 | 22,879,160 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $7M | $9M | $8M | $7M | $5M | $2M | $129.0K | $10M | $8M | $10M | $9M | $2M | |
| Restructuring | · | · | · | · | · | · | $6M | · | · | $1M | · | · | |
| Operating Cash Flow | $-113M | $-71M | $-33M | $-28M | $-42M | $-42M | $-23M | $-51M | $-44M | $-52M | $-60M | $-28M | |
| CapEx | $91.0K | $515.0K | $164.0K | $100.0K | $333.0K | $62.0K | $83.0K | $108.0K | $55.0K | $660.0K | $595.0K | $58.0K | |
| Investing Cash Flow | $100M | $-85M | $33M | $-91M | $24M | $17M | $-83.0K | $-7M | $36M | $51M | · | · | |
| Stock Issued | $65M | $162M | · | $75M | $20M | $76M | · | $65M | · | · | $130M | $103M | |
| Net Stock Activity | $65M | $162M | · | $75M | $20M | $76M | · | $65M | · | · | · | · | |
| Financing Cash Flow | $65M | $162M | $30.0K | $75M | $20M | $94M | $19M | $67M | $17M | $-3M | · | · | |
| Net Change in Cash | $52M | $6M | $-76.0K | $-43M | $2M | $68M | $-3M | $9M | $8M | $-3M | $-23M | $23M | |
| Free Cash Flow | $-113M | $-71M | $-34M | $-28M | $-42M | $-42M | $-42M | $-52M | $-44M | $-53M | · | $-28M | |
| Levered FCF | · | · | · | · | · | · | $-43M | $-53M | $-44M | $-53M | · | $-29M |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -95.8% | -54.4% | -33.2% | -34.5% | -55.2% | -77.3% | -44.9% | -54.0% | -43.9% | -36.1% | · | -46.9% | |
| ROE | -167.4% | -43.5% | -42.4% | -30.8% | -74.2% | -44.2% | -163.6% | -62.2% | -52.0% | -39.8% | · | -203.4% | |
| ROIC | -220.9% | -52.9% | -51.1% | -32.9% | -78.3% | -47.7% | -75.0% | -61.9% | -67.8% | -46.5% | · | -33.6% |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.2 | 8.0 | 9.5 | 11.3 | 8.2 | 10.9 | 5.9 | 9.1 | 14.4 | 13.2 | · | 17.0 | |
| Quick Ratio | 1.3 | 1.4 | 2.8 | 2.5 | 7.9 | 7.6 | 2.2 | 3.7 | 5.6 | 3.3 | · | 8.4 | |
| Debt / Equity | · | · | · | · | · | · | 0.1 | 0.1 | · | 0.0 | · | 0.0 | |
| Interest Coverage | · | · | · | · | · | · | -25.9 | -32.2 | -321.2 | -110.1 | · | -40.8 |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | 0.0 | 0.0 | 0.0 | 0.0 | · | 0.0 |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.94 | $2.69 | $1.86 | $2.56 | $3.64 | $5.84 | $1.43 | $2.50 | $2.85 | $4.45 | · | $4.56 | |
| Cash Flow / Share | · | $-1.16 | $-0.76 | $-1.07 | $-2.45 | · | · | · | · | · | · | · | |
| Cash / Share | $1.03 | $0.52 | $0.61 | $0.62 | $3.96 | $4.43 | $0.73 | $1.32 | $1.48 | $1.18 | · | $2.54 | |
| EPS (TTM) | $-1.72 | $-1.32 | $-0.84 | $-1.37 | $-2.95 | $-3.57 | · | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income TTM | $-166M | $-81M | $-37M | $-35M | $-51M | $-42M | $-23M | $-61M | $-52M | $-58M | $-74M | $-36M | |
| Market Cap | $317M | $247M | $200M | $179M | $191M | $329M | $499M | $2.21B | $1.52B | $1.04B | · | $8.47B | |
| Enterprise Value | · | · | · | · | · | · | $479M | $2.17B | · | $1.01B | · | $8.41B | |
| P/E | -2.2 | -2.9 | -5.4 | -3.0 | -3.7 | -6.0 | · | · | · | · | · | · | |
| P/B | 4.1 | 1.4 | 2.4 | 1.6 | 3.0 | 3.7 | 9.3 | 23.7 | 19.5 | 8.6 | · | 81.1 | |
| P / Tangible Book | 4.1 | 1.4 | 2.4 | 1.6 | 3.0 | 3.7 | · | · | · | · | · | · | |
| P / Cash Flow | -2.8 | -3.5 | -6.0 | -6.5 | -4.5 | -7.8 | -12.2 | -43.0 | -34.8 | -20.1 | · | -299.8 | |
| P / FCF | -2.8 | -3.5 | -5.9 | -6.5 | -4.5 | -7.8 | -12.0 | -42.9 | -34.8 | -19.8 | · | -299.2 | |
| EV / EBITDA | · | · | · | · | · | · | -10.5 | -35.5 | · | -17.4 | · | -236.7 | |
| EV / FCF | · | · | · | · | · | · | -11.5 | -42.1 | · | -19.3 | · | -297.2 | |
| Earnings Yield | -45.1% | -34.1% | -18.5% | -33.2% | -27.3% | -16.7% | · | · | · | · | · | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $28M | $25M | $59M | $45M | $23M | $27M | $27M | $14M | $20M | $13M | $11M | $7M | $6M | $5M | $7M | $6M | |
| SG&A Expense | $6M | $6M | $5M | $5M | $4M | $5M | $5M | $4M | $5M | $4M | $4M | $4M | $4M | $3M | $3M | $3M | |
| Operating Expenses | $34M | $31M | $64M | $49M | $28M | $31M | $31M | $18M | $25M | $17M | $14M | $10M | $10M | $8M | $10M | $9M | |
| Operating Income | $-34M | $-31M | $-64M | $-49M | $-28M | $-31M | $-31M | $-18M | $-25M | $-17M | $-14M | $-10M | $-10M | $-8M | $-10M | $-9M | |
| Other Non-op | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $2M | $1M | $1M | $1M | $1M | $1M | $193.0K | |
| Income Tax | · | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | · | · | · | · | · | · | |
| Net Income | $-33M | $-30M | $-62M | $-48M | $-26M | $-29M | $-29M | $-15M | $-22M | $-15M | $-13M | $-9M | $-8M | $-7M | $-9M | $-8M | |
| EPS (Basic) | · | · | · | $-0.61 | $-0.41 | $-0.46 | · | $-0.24 | $-0.34 | $-0.27 | $-0.29 | $-0.21 | $-0.19 | $-0.15 | $-0.04 | $-0.37 | |
| EPS (Diluted) | · | · | · | $-0.61 | $-0.41 | $-0.46 | · | $-0.24 | $-0.34 | $-0.27 | $-0.29 | $-0.21 | $-0.19 | $-0.15 | $-0.04 | $-0.37 | |
| Shares (Basic) | · | · | · | 78,324,767 | 64,027,892 | 63,964,008 | · | 63,806,158 | 63,801,792 | 53,553,707 | · | 43,903,738 | 43,897,603 | 43,897,603 | · | 22,228,228 | |
| Shares (Diluted) | · | · | · | 78,324,767 | 64,027,892 | 63,964,008 | · | 63,806,158 | 63,801,792 | 53,553,707 | · | 43,903,738 | 43,897,603 | 43,897,603 | · | 22,228,228 | |
| EBITDA | $-34M | $-31M | · | $-49M | $-28M | $-31M | · | $-18M | $-25M | $-17M | · | $-10M | $-10M | $-8M | · | $-9M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $93M | $178M | $85M | $90M | $21M | $21M | $33M | $35M | $32M | $110M | $27M | $39M | $94M | $112M | $27M | $86M | |
| Prepaid Expense | $4M | $5M | $5M | $8M | $7M | $8M | $12M | $10M | $5M | $4M | $3M | $3M | $2M | $2M | $2M | $2M | |
| Current Assets | $161M | $205M | $142M | $183M | $146M | $165M | $195M | $213M | $231M | $231M | $90M | $98M | $106M | $113M | $121M | $127M | |
| PP&E (Net) | $639.0K | $558.0K | $622.0K | $709.0K | $797.0K | $855.0K | $881.0K | $779.0K | $844.0K | $604.0K | $684.0K | $601.0K | $677.0K | $753.0K | $831.0K | $909.0K | |
| PP&E (Gross) | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Accum. Depreciation | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $992.0K | $914.0K | $836.0K | |
| Other Non-current Assets | $480.0K | $504.0K | $523.0K | $542.0K | $561.0K | $582.0K | $596.0K | $621.0K | $636.0K | $678.0K | $659.0K | $634.0K | $644.0K | $632.0K | $638.0K | $643.0K | |
| Total Assets | $165M | $209M | $146M | $187M | $150M | $170M | $200M | $219M | $237M | $248M | $96M | $104M | $112M | $119M | $126M | $133M | |
| Accounts Payable | $8M | $9M | $5M | $11M | $4M | $2M | $2M | $2M | $3M | $2M | $1M | $756.0K | $2M | $695.0K | $2M | $849.0K | |
| Accrued Liabilities | $25M | $38M | $58M | $33M | $21M | $19M | $21M | $14M | $17M | $10M | $7M | $5M | $4M | $7M | $8M | $8M | |
| Current Liabilities | $34M | $48M | $65M | $45M | $27M | $22M | $24M | $16M | $21M | $13M | $10M | $7M | $7M | $8M | $11M | $9M | |
| Capital Leases | $4M | $3M | $3M | $3M | $3M | $4M | $4M | $4M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | |
| Total Liabilities | $38M | $50M | $68M | $48M | $30M | $26M | $28M | $21M | $26M | $17M | $14M | $11M | $12M | $13M | $16M | $14M | |
| Common Stock | $103.0K | $103.0K | $83.0K | $86.0K | $64.0K | $64.0K | $64.0K | $64.0K | $64.0K | $64.0K | $43.0K | $43.0K | $43.0K | $43.0K | $43.0K | $43.0K | |
| Paid-in Capital | $625M | $622M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Retained Earnings | $-497M | $-464M | $-435M | $-372M | $-325M | $-298M | $-269M | $-240M | $-225M | $-203M | $-189M | $-176M | $-166M | $-158M | $-152M | $-142M | |
| AOCI | $-12.0K | $6.0K | $54.0K | $66.0K | $-9.0K | $54.0K | $148.0K | $358.0K | $-150.0K | $-25.0K | $81.0K | $7.0K | $12.0K | · | $-31.0K | $-40.0K | |
| Stockholders' Equity | $127M | $158M | $78M | $139M | $120M | $144M | $172M | $198M | $211M | $231M | $82M | $93M | $100M | $106M | $111M | $119M | |
| Liabilities + Equity | $165M | $209M | $146M | $187M | $150M | $170M | $200M | $219M | $237M | $248M | $96M | $104M | $112M | $119M | $126M | $133M | |
| Shares Outstanding | 103,882,937 | 103,882,937 | 83,090,392 | 85,590,392 | 64,027,892 | 64,027,892 | 63,815,065 | 63,806,628 | 63,802,517 | 63,800,017 | 43,909,069 | 43,905,903 | 43,269,200 | 43,269,200 | 43,269,200 | 43,269,200 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Operating Cash Flow | $-44M | $-45M | · | · | $-19M | $-27M | $-22M | $-25M | $-14M | $-10M | $-9M | $-9M | $-7M | $-8M | $-7M | $-6M | |
| CapEx | · | · | $0 | $23.0K | $19.0K | $49.0K | $179.0K | $62.0K | · | · | · | · | · | · | $0 | $0 | |
| Investing Cash Flow | $-41M | $29M | · | · | $19M | $14M | $19M | $27M | $-63M | $-68M | $-3M | $-46M | $-10M | $92M | $-52M | $-3M | |
| Stock Issued | · | · | $-201.0K | · | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-435.0K | $108M | · | · | · | · | $36.0K | $30.0K | $-334.0K | $162M | $0 | · | · | · | $-316.0K | · | |
| Net Change in Cash | $-85M | $93M | $-5M | $70M | $-539.0K | $-12M | $-3M | $3M | $-78M | $83M | $-12M | $-56M | $-17M | $85M | $-59M | $66M | |
| Free Cash Flow | · | · | · | · | · | $-27M | · | · | · | · | · | · | · | · | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -20.8% | -15.6% | · | -23.5% | -13.5% | -14.0% | · | -9.6% | -12.4% | -8.0% | · | -7.6% | -9.6% | -6.9% | · | -7.5% | |
| ROE | -26.5% | -19.6% | · | -28.3% | -15.8% | -15.6% | · | -10.7% | -13.9% | -8.7% | · | -8.6% | -11.2% | -8.0% | · | -8.7% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.7 | 4.3 | · | 4.1 | 5.5 | 7.5 | · | 13.1 | 10.9 | 18.0 | · | 15.0 | 14.6 | 14.2 | · | 13.5 | |
| Quick Ratio | 2.7 | 3.7 | · | 2.0 | 0.8 | 1.0 | · | 2.2 | 1.5 | 8.6 | · | 5.9 | 13.0 | 13.9 | · | 9.1 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.23 | $1.52 | · | $1.62 | $1.87 | $2.25 | · | $3.11 | $3.31 | $3.62 | · | $2.11 | $2.31 | $2.46 | · | $2.74 | |
| Cash Flow / Share | · | · | · | · | · | $-0.41 | · | · | · | $-0.19 | · | · | · | $-0.17 | · | · | |
| Cash / Share | $0.89 | $1.71 | · | $1.05 | $0.32 | $0.33 | · | $0.55 | $0.51 | $1.73 | · | $0.88 | $2.18 | $2.58 | · | $1.99 | |
| EPS (TTM) | · | · | · | · | · | · | · | $-1.14 | $-1.11 | $-0.96 | · | $-0.59 | $-0.75 | $-1.03 | · | $-1.81 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | |
| Net Income TTM | $-173M | $-166M | · | $-132M | $-100M | $-95M | · | $-65M | $-58M | $-45M | · | $-33M | $-33M | $-33M | · | $-35M | |
| Market Cap | $317M | $467M | · | $276M | $185M | $138M | · | $418M | $463M | $484M | · | $173M | $135M | $196M | · | $138M | |
| P/E | · | · | · | · | · | · | · | -5.7 | -6.5 | -7.9 | · | -6.7 | -4.2 | -4.4 | · | -1.8 | |
| P/B | 2.5 | 3.0 | · | 2.0 | 1.5 | 1.0 | · | 2.1 | 2.2 | 2.1 | · | 1.9 | 1.4 | 1.8 | · | 1.2 | |
| P / Tangible Book | 2.5 | 3.0 | · | 2.0 | 1.5 | 1.0 | · | 2.1 | 2.2 | 2.1 | · | 1.9 | 1.4 | 1.8 | · | 1.2 | |
| P / Cash Flow | · | -10.5 | · | · | · | -5.2 | · | · | · | -46.5 | · | · | · | -26.0 | · | · | |
| Earnings Yield | · | · | · | · | · | · | · | -17.4% | -15.3% | -12.7% | · | -14.9% | -24.0% | -22.7% | · | -56.6% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Nettoergebnis | $-166M | $-81M | $-37M | $-35M | $-51M |
| Verwässerte EPS | · | $-1.32 | $-0.84 | $-1.37 | $-2.95 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Liquiditätsgrad | 2.2 | 8.0 | 9.5 | 11.3 | 8.2 |
| Quick Ratio | 1.3 | 1.4 | 2.8 | 2.5 | 7.9 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $-113M | $-71M | $-34M | $-28M | $-42M |
Institutionelle Eigentümer (13F) 178 Einreicher · $309.2M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
178
Gehaltener Wert
$309.2M
Neue Positionen
31
Geschlossene Positionen
29
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 31 (-21 vs. Vorquartal) | 29 (+15 vs. Vorquartal) | 70 (+12 vs. Vorquartal) | 44 (+3 vs. Vorquartal) | +7.7M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. | $108.601.271 | 35.606.974 | 35,13% | Aktien |
| Blue Owl Capital Holdings LP | $27.947.629 | 9.163.157 | 9,04% | Aktien |
| BlackRock, Inc. | $17.318.006 | 5.678.035 | 5,60% | Aktien |
| VANGUARD GROUP INC | $11.606.083 | 3.046.216 | 3,75% | Aktien |
| Defilade Capital Management, L.P. | $11.193.912 | 3.670.135 | 3,62% | Aktien |
| Driehaus Capital Management LLC | $9.648.440 | 3.163.423 | 3,12% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $9.073.448 | 2.974.901 | 2,93% | Aktien |
| RTW INVESTMENTS, LP | $7.826.297 | 2.565.999 | 2,53% | Aktien |
| AQR CAPITAL MANAGEMENT LLC | $7.232.813 | 2.371.414 | 2,34% | Aktien |
| MARSHALL WACE, LLP | $6.137.996 | 2.012.458 | 1,99% | Aktien |
| DAFNA Capital Management LLC | $6.124.900 | 2.008.164 | 1,98% | Aktien |
| GOLDMAN SACHS GROUP INC | $5.346.375 | 1.752.910 | 1,73% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $5.121.921 | 1.679.003 | 1,66% | Aktien |
| Qube Research & Technologies Ltd | $5.005.178 | 1.641.042 | 1,62% | Aktien |
| CITADEL ADVISORS LLC | $4.443.316 | 1.456.825 | 1,44% | Aktien |
| STATE STREET CORP | $4.306.002 | 1.411.804 | 1,39% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $4.279.675 | 1.403.172 | 1,38% | Aktien |
| Woodline Partners LP | $4.272.593 | 1.400.850 | 1,38% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $4.065.763 | 1.333.037 | 1,32% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $2.932.299 | 961.083 | 0,95% | Aktien |
| FMR LLC | $2.858.971 | 937.368 | 0,92% | Aktien |
| SPHERA FUNDS MANAGEMENT LTD. | $2.824.312 | 926.004 | 0,91% | Aktien |
| Nuveen, LLC | $2.730.677 | 895.304 | 0,88% | Aktien |
| Alyeska Investment Group, L.P. | $1.882.494 | 617.211 | 0,61% | Aktien |
| NORTHERN TRUST CORP | $1.678.311 | 550.266 | 0,54% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1.580.815 | 518.300 | 0,51% | Verkaufsoption |
| VANGUARD FIDUCIARY TRUST CO | $1.366.912 | 448.168 | 0,44% | Aktien |
| Fi3 FINANCIAL ADVISORS, LLC | $1.263.896 | 2.915 | 0,41% | Aktien |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $1.218.604 | 399.542 | 0,39% | Aktien |
| SummitTX Capital, L.P. | $1.074.466 | 352.284 | 0,35% | Aktien |
| JPMORGAN CHASE & CO | $1.049.648 | 328.015 | 0,34% | Aktien |
| Gem Investment Advisors, LLC | $974.533 | 319.519 | 0,32% | Aktien |
| Burkehill Global Management, LP | $915.000 | 300.000 | 0,30% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $907.201 | 297.443 | 0,29% | Aktien |
| HAP Trading, LLC | $848.766 | 262.776 | 0,27% | Aktien |
| ADAR1 Capital Management, LLC | $831.872 | 272.745 | 0,27% | Aktien |
| Cerity Partners LLC | $828.326 | 271.582 | 0,27% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $821.975 | 269.500 | 0,27% | Kaufoption |
| CITADEL ADVISORS LLC | $732.610 | 240.200 | 0,24% | Verkaufsoption |
| TWO SIGMA INVESTMENTS, LP | $720.206 | 236.133 | 0,23% | Aktien |
| Seven Fleet Capital Management LP | $704.309 | 230.921 | 0,23% | Aktien |
| HAP Trading, LLC | $687.173 | 237.776 | 0,22% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $631.255 | 206.969 | 0,20% | Aktien |
| IEQ CAPITAL, LLC | $620.258 | 203.363 | 0,20% | Aktien |
| Caption Management, LLC | $588.705 | 193.018 | 0,19% | Aktien |
| Soleus Capital Management, L.P. | $573.711 | 188.102 | 0,19% | Aktien |
| Cubist Systematic Strategies, LLC | $523.775 | 162.159 | 0,17% | Aktien |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $520.254 | 170.575 | 0,17% | Aktien |
| Susquehanna Portfolio Strategies, LLC | $503.726 | 165.156 | 0,16% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $486.990 | 108.220 | 0,16% | Aktien |
Aktivisten & 5%+-Eigentümer 3 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Deerfield Private Design Fund III, L.P., Deerfield Healthcare Innovations Fund, L.P., Deerfield Private Design Fund IV, L.P., Deerfield Partners, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt HIF, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt, L.P., Deerfield Management Company, L.P., James E. Flynn ×12 Einreichungen | 2. März 2026 | 34,41% | Änderung | Passive Anlage | SEC |
| Chondrial Therapeutics Holdings, LLC ×2 Einreichungen | 30. Juni 2020 | · | Erste Einreichung | · | SEC |
| Chondrial Therapeutics, Inc. | 27. Dezember 2019 | · | Erste Einreichung | M&A / Verkauf | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 29 Insider · 13 Führungskräfte · 18 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Carole Ben-Maimon | President and CEO | 26. Januar 2026 A | 368.276 | 0 | 0 | $0 |
| Jeffrey S. Hatfield | Chief Executive Officer | 22. Januar 2019 A | · | 0 | 0 | $0 |
| Michael Celano | Chief Financial Officer | 26. Januar 2026 A | 215.785 | 0 | 0 | $0 |
| Patricia L Allen | Chief Financial Officer | 22. Januar 2019 A | 19.793 | 0 | 0 | $0 |
| John B. Harlow Jr. | President and COO | 29. September 2026 A | 50.000 | 0 | 0 | $0 |
| Thomas E. Hughes | President and Chief Scientific Officer | 28. Juni 2018 S | 125.247 | 0 | 0 | $0 |
| Patrick Loustau | President | 31. März 2016 A | · | 0 | 0 | $0 |
| Gopi Shankar | Chief Development Officer | 26. Januar 2026 A | 76.443 | 0 | 0 | $0 |
| Russell Clayton | Chief Medical Officer | 26. Januar 2026 A | 71.443 | 0 | 0 | $0 |
| Singhal Priya | Head of Research & Development | 2. April 2019 A | · | 0 | 0 | $0 |
| Brian Mcveigh | Chief Business Officer | 22. Januar 2019 A | · | 0 | 0 | $0 |
| Dennis D Kim | Chief Medical Officer | 22. Januar 2019 A | 21.443 | 0 | 0 | $0 |
| Alicia Secor | Chief Commercial Officer | 31. März 2016 A | 0 | 0 | 0 | $0 |
| Thomas Edward Hamilton | Direktor | 6. Juli 2026 P | 714.798 | 2 | 0 | $667.000 |
| Joseph Truitt | Direktor | 19. Mai 2026 A | 2.750 | 0 | 0 | $0 |
| Frank E Thomas | Direktor | 19. Mai 2026 A | 7.000 | 1 | 0 | $25.000 |
| Jeffrey W Sherman | Direktor | 19. Mai 2026 A | 5.000 | 1 | 0 | $25.000 |
| Jonathan S Leff | Direktor | 19. Mai 2026 A | · | 0 | 0 | $0 |
| Peter Barrett | Direktor | 10. Mai 2022 A | 4.643.327 | 0 | 0 | $0 |
| Thomas O Daniel | Direktor | 12. Mai 2021 A | 19.452 | 0 | 0 | $0 |
| Wendy Everett | Direktor | 26. Juni 2019 A | · | 0 | 0 | $0 |
| Cameron Geoffrey Mcdonough | Direktor | 26. Juni 2019 A | 0 | 0 | 0 | $0 |
| Robert J Perez | Direktor | 26. Juni 2019 A | 5.322 | 0 | 0 | $0 |
| John L Lamattina | Direktor | 26. Juni 2019 A | 31.376 | 0 | 0 | $0 |
| Bruce Booth | Direktor | 3. Januar 2018 A | 4.638.028 | 0 | 0 | $0 |
| Frances K Heller | Direktor | 13. Oktober 2017 P | 47.961 | 0 | 0 | $0 |
| Kevin P Starr | Direktor | 24. September 2015 J | 370.323 | 0 | 0 | $0 |
| Avi Y. Goldberg | Direktor | 18. September 2015 S | 53.734 | 0 | 0 | $0 |
| CHONDRIAL THERAPEUTICS HOLDINGS, LLC | 10%-Eigentümer | 26. Juni 2020 J | 8 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 21 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| IBRN · iShares Trust | 0,21% | 4.010 SH | 11. September 2026 | Täglich |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,11% | 92.953 SH | 1. Oktober 2026 | Täglich |
| IWC · iShares Trust | 0,06% | 225.822 SH | 11. September 2026 | Täglich |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,02% | 7.348 SH | 1. Oktober 2026 | Täglich |
| IWO · iShares Trust | 0,02% | 625.151 SH | 11. September 2026 | Täglich |
| IBB · iShares Trust | 0,01% | 394.961 SH | 11. September 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 382.844 SH | 19. August 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,01% | 71.780 SH | 19. August 2026 | Täglich |
| DFAS · Dimensional ETF Trust | 0,01% | 340.789 NS | 31. Juli 2026 | N-PORT |
| IWM · iShares Trust | 0,01% | 1.693.182 SH | 11. September 2026 | Täglich |
| RSSL · Global X Funds | 0,01% | 31.780 NS | 31. Juli 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,00% | 4.394 NS | 31. Juli 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,00% | 12.923 NS | 31. Juli 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 11.721 NS | 31. Juli 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 105.245 NS | 31. Juli 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 17.386 SH | 10. September 2026 | Täglich |
| DFAU · Dimensional ETF Trust | 0,00% | 11.156 NS | 31. Juli 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 699.471 SH | 19. August 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 2.206.446 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 7.400 SH | 19. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,00% | 172.125 SH | 19. August 2026 | Täglich |
LRMR Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 17 Analysten
KAUF
Median-Ziel
$13.00
+339,2%
8 47,1%
Starker Kauf
8 47,1%
Kauf
1 5,9%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
10 Analysten · 2026-09-29Mittelwert-Ziel $14.40 +386,5%
← Unter allen Zielen
Aktueller Preis $2.96
Tief$5.00
Mittelwert$14.40
Hoch$26.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| LRMR | $317M | -2.2 | · | · | -167.4% | · |
| BBOT | $1.00B | -2.9 | · | · | -146.2% | · |
| BNTC | $460M | -13.7 | · | · | -25.0% | · |
| SCTX | · | · | · | · | · | · |
| CABA | $220M | -1.0 | · | · | -115.5% | · |
| PRLD | · | -2.2 | 73.4% | -819.6% | -137.7% | · |
| LXEO | $725M | -5.3 | · | · | -51.9% | · |
| ABEO | $290M | 5.2 | 147.5% | 1223.1% | 44.1% | · |
| VNDA | $521M | -2.4 | 8.7% | -102.0% | -54.2% | · |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 4, 2026